Integrity Alliance LLC. Reduces Stock Holdings in UnitedHealth Group Incorporated $UNH

Integrity Alliance LLC. lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 48.1% in the second quarter, Holdings Channel.com reports. The firm owned 6,948 shares of the healthcare conglomerate’s stock after selling 6,447 shares during the period. Integrity Alliance LLC.’s holdings in UnitedHealth Group were worth $2,168,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of UNH. Nuveen LLC acquired a new stake in UnitedHealth Group during the 1st quarter valued at approximately $3,846,764,000. Vanguard Group Inc. grew its position in shares of UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after acquiring an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP increased its holdings in shares of UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after acquiring an additional 2,486,839 shares during the last quarter. National Bank of Canada FI increased its holdings in shares of UnitedHealth Group by 137.8% in the 1st quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock valued at $859,518,000 after acquiring an additional 950,928 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of UnitedHealth Group by 13.6% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock valued at $3,702,736,000 after acquiring an additional 847,054 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 1.0%

Shares of UnitedHealth Group stock opened at $341.46 on Friday. The business’s fifty day moving average price is $343.51 and its two-hundred day moving average price is $329.40. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85. The company has a market capitalization of $309.25 billion, a P/E ratio of 17.82, a PEG ratio of 2.28 and a beta of 0.47. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating the consensus estimate of $2.87 by $0.05. The firm had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The firm’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $7.15 EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. UnitedHealth Group’s dividend payout ratio is 46.14%.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research analyst reports. Cantor Fitzgerald reiterated an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Bank of America boosted their price target on UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a report on Wednesday, October 8th. TD Cowen boosted their price objective on UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a research report on Thursday. Robert W. Baird restated an “underperform” rating and set a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Finally, UBS Group boosted their price objective on UnitedHealth Group from $378.00 to $430.00 and gave the company a “buy” rating in a research report on Wednesday. Eighteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average price target of $397.12.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.